Odaily星球日报讯 据 Prnewswire 报道，美股上市生物制药公司 Galmed Pharmaceuticals Ltd.宣布实施数字资产管理战略，公司计划将 1000 万美元（约占当前现金储备的 50%）用于数字资产投资。公司已成立加密货币委员会，负责评估和监督加密货币相关投资活动。该策略将包括数字资产投资组合再平衡、参与流动性提供、质押收益和风险对冲策略等。为执行该计划，Galmed 已与加密货币资产管理服务商 Tectona（TASE：TECT）签署意向书，由后者提供咨询和运营服务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.